Single-arm open-label trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 3000202 in adult patients with selected type 1 interferonopathies (BI_1509-0003)

The aim of this trial is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of BI 3000202 (administered on top of stable standard of care, if any) in adult patients with selected type 1 interferonopathies.